首页> 外文期刊>Nature >Activation of specific RXR heterodimers by an antagonist of RXR homodimers.
【24h】

Activation of specific RXR heterodimers by an antagonist of RXR homodimers.

机译:RXR同二聚体的拮抗剂激活特定的RXR异二聚体。

获取原文
获取原文并翻译 | 示例
           

摘要

Retinoid X receptor (RXR) plays a central role in the regulation of many intracellular receptor signalling pathways and can mediate ligand-dependent transcription, acting as a homodimer or as a heterodimer. Here we identify an antagonist towards RXR homodimers which also functions as an agonist when RXR is paired as a heterodimer to specific partners, including peroxisome proliferator-activated receptor and retinoic acid receptor. This dimer-selective ligand confers differential interactions on the transcription machinery: the antagonist promotes association with TAF110 (TATA-binding protein (TBP)-associated factor 110) and the co-repressor SMRT, but not with TBP, and these properties are distinct from pure RXR agonists. This unique class of RXR ligands will provide a means to control distinct target genes at the level of transcription and allow the development of retinoids with a new pharmacological action.
机译:类视黄醇X受体(RXR)在许多细胞内受体信号传导途径的调节中起着核心作用,并且可以介导配体依赖性转录,作为同二聚体或异二聚体。在这里,我们确定了针对RXR同型二聚体的拮抗剂,当RXR与异型二聚体配对时,它也可以作为激动剂与特定的伴侣配对,包括过氧化物酶体增殖物激活受体和视黄酸受体。这种二聚体选择性配体赋予了转录机制不同的相互作用:拮抗剂促进与TAF110(TATA结合蛋白(TBP)相关因子110)和共阻遏物SMRT的结合,但不与TBP结合,这些特性与纯RXR激动剂。这类独特的RXR配体将提供一种在转录水平上控制不同靶基因的方法,并允许以新药理作用开发类维生素A。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号